Prevalence of Extrapulmonary Tuberculosis in Newly Registered HIV Patients
Abstract
Introduction: Human Immunodeficiency Virus infection and Tuberculosis are among the ten leading causes of death worldwide. In advanced AIDS, M. tuberculosis frequently causes disseminated Extra-Pulmonary Tuberculosis (EPTB). EPTB being paucibacillary infection poses a diagnostic challenge. The emergence of Cartridge Based Nucleic Acid Amplification Test (CBNAAT) has marked an important development in the field of rapid molecular diagnostics of tuberculosis.
Aims and Objective: The purpose of this study was to determine the prevalence of EPTB in newly registered HIV patients visiting ART clinic and to find the prevalence of Rifampicin resistance using CBNAAT.
Materials and Method: 213 newly registered HIV patients were included in the study recruited over 10 months time period and followed up for six months from recruitment. Case record of each patient with detailed history, clinical examination and necessary blood, radiological and specimen sampling done to investigate for tuberculosis was maintained. The data obtained were analyzed using SPSS 20.0 software.
Result: The prevalence of EPTB in newly registered HIV patients was found to be 14.5%, with abdomen being the most common site for EPTB. Rifampicin resistance was seen in 3.2% cases.
Conclusion: The result of this study showed that the prevalence of EPTB was higher compared to PTB in HIV patients. CBNAAT sensitivity for different samples were variable. This study showed maximum sensitivity of CBNAAT for lymph node aspirate (100%) and minimum for CSF (0%). Overall the sensitivity of CBNAAT was low, yet it is a very useful investigation for detection of EPTB with high positive predictive value.
How to cite this article:
Kumar K, Inamdar SS, Avasthi R, Maroof KA, Rathi V, Sharma B. Prevalence of Extrapulmonary Tuberculosis in newly Registered HIV Patients. J Adv Res Med 2020; 7(4): 7-10.
DOI: https://doi.org/10.24321/2349.7181.202017
References
Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C. The growing burden of
tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163(9): 1009-21.
Centers for Disease Control. Revision of the CDC surveillance case definition for acquired
immunodeficiency syndrome. MMWR 1987; 36: 1-15.
Indian Council of Medical Research. Index Tb guidelines: Guidelines on extrapulmonary tuberculosis for India.
ICMR, Central Tb Division and Ministry of Health and Family Welfare.2016. Available at
guidelines/TB/index-TB%20Guidelines% 20>. Accessed on 9 Sep 2017.
Tortoli E, Russo C, Piersimoni C, Mazzola E, Dal Monte P, Pascarella M et al. Clinical validation of Xpert MTB/
RIF for the diagnosis of extrapulmonary tuberculosis. Eur Respir J 2012; 40(2): 442-7.
Indian Council of Medical Research. Index Tb guidelines: Guidelines on extrapulmonary tuberculosis for India.
ICMR, Central Tb Division and Ministry of Health and Family Welfare.2016. Available at
guidelines/TB/index-TB%20Guidelines% 20>. Accessed on 9 Sep 2017.
Time to act. Save a million lives by 2015. Prevent and treat tuberculosis among people living withHIV.
[http://www.stoptb.org/assets/documents/ resources/publications/acsm/TB_HIV_Brochure_Singles.pdf]
Prakasha SR, Suresh G, D’sa IP, Shetty SS, Kumar SG. Mapping the pattern and trends of extrapulmonary
tuberculosis. Journal of global infectious diseases 2013; 5(2): 54.
Mohammed H, Assefa N, Mengistie B. Prevalence of extrapulmonary tuberculosis among people living with
HIV/AIDS in sub-Saharan Africa: a systemic review and meta-analysis. HIV/AIDS (Auckland, NZ). 2018; 10: 225.
Denkinger CM, Schumacher SG, Boehme CC, Dendukuri N, Pai M, Steingart KR. Xpert MTB/RIF assay for the
diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. European Respiratory Journal
; 44(2): 435-46.
Goyal V, Kadam V, Narang P, Singh V. Prevalence of drugresistant pulmonary tuberculosis in India: systematic
review and meta-analysis. BMC public health 2017; 17(1): 817.
Central TB Division. TB India 2016. RNTCP Annual Status Report. New Delhi: Ministry of Health and Family
Welfare; 2016. http://www.tbcindia.nic.in/index1.php?lang=1&level=1&sublinkid=4160&lid=2807. Accessed9 Feb 2017.
World Health Organization. The Global Tuberculosis Report: 2016. Geneva, Switzerland: WHO, 2016. http://
www.who.int/tb/publications/global_report/en/.Accessed 2017, Feb 9.
Komanapalli SK, Atla UPB, Vasundhara N, Yendluri D. Role of CB-NAAT in diagnosing extra pulmonary
tuberculosis in correlation with FNA in a tertiary care center. Int J Res Med Sci 2018; 6(12): 4039-4045.
Tripathi R, Kashyap S, Chaubey P, Pandey AP, Anupurba S. Role of cartridge-based nucleic acid amplification test in detection of pulmonary tuberculosis in people living with human immunodeficiency virus. Journal of The
Academy of Clinical Microbiologists 2017; 19(2): 114.
Gupta M, Purohit G, Vyas S. Prevalence of positivity of CBNAAT (cartridge based nucleic acid amplification test) in extra-pulmonary tuberculosis. European Respiratory Journal 2018 52: Suppl. 62, PA2756.
